Monograph Details
|
|
Endocrine System
> Hypogonadism
|
|
ANDROID |
| Manufacturer |
|
Valeant Pharmaceuticals, Inc |
| Legal Classification |
|
CIII |
| Pharmacological Class |
|
Androgen. |
| Generic Name |
|
Methyltestosterone 10mg; caps. |
| Indications |
|
In males, primary and secondary hypogonadism, delayed puberty. |
| Adults and Children |
|
Usually 10–50mg daily. Delayed puberty: use low dose and limit duration to 4–6 months. |
| Contraindications |
|
Male breast or prostate carcinoma. Pregnancy (Cat.X). |
| Precautions |
|
Discontinue if jaundice, abnormal liver function, hypercalcemia, or edema occurs. Cardiac, hepatic, or renal dysfunction. Monitor hepatic function, blood, and bone age. Elderly. Young children. Nursing mothers: not recommended. |
| Interactions |
|
May potentiate oral anticoagulants, oxyphenbutazone. May alter insulin needs. |
| Adverse Reactions |
|
Peliosis hepatis, premature epiphyseal closure in adolescents, edema, hepatic carcinoma, prostatic hypertrophy or carcinoma, gynecomastia, priapism, oligospermia, nausea, jaundice, hirsutism, virilization, male pattern baldness, acne, polycythemia, headache, anxiety, depression, paresthesias, altered libido, fluid and electrolyte disturbances, suppression of clotting factors, increased serum cholesterol. |
| How Supplied |
|
Caps—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
